|
|||
Names | |||
---|---|---|---|
IUPAC name
1-Methyl-3-(2-methylpropyl)-7H-purine-2,6-dione
|
|||
Other names
3-Isobutyl-1-methylxanthine
|
|||
Identifiers | |||
28822-58-4 ![]() |
|||
3D model (Jmol) | Interactive image | ||
ChEBI |
CHEBI:34795 ![]() |
||
ChEMBL |
ChEMBL275084 ![]() |
||
ChemSpider |
3627 ![]() |
||
DrugBank |
DB07954 ![]() |
||
ECHA InfoCard | 100.044.767 | ||
388 | |||
KEGG |
C13708 ![]() |
||
PubChem | 3758 | ||
UNII |
TBT296U68M ![]() |
||
|
|||
|
|||
Properties | |||
C10H14N4O2 | |||
Molar mass | 222.3 g/mol | ||
Appearance | White solid | ||
Melting point | 199 to 201 °C (390 to 394 °F; 472 to 474 K) | ||
Solubility | Soluble in ethanol, DMSO, and methanol | ||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|||
![]() ![]() ![]() |
|||
Infobox references | |||
IBMX (3-isobutyl-1-methylxanthine), like other methylated xanthine derivatives, is both a:
As a phosphodiesterase inhibitor, IBMX has IC50 = 2–50 μM and does not inhibit PDE8 or PDE9.